Description: This session will highlight the growing significance of climate risk for insurance companies, emphasizing how to prepare for regulatory requirements as well as the impacts on financial stability and operational resilience within the industry. Attendees will gain insights specifically addressing climate risk within insurance operations including enhancing governance structures, ensuring regulatory compliance, identifying and monitoring metrics and key risk indicators, and conducting scenario analyses. Through real-world case studies and perspectives from both life and P&C practitioners, participants will leave equipped with practical strategies to navigate the complexities of climate risk management, foster transparency and accountability, and effectively address the urgent challenges posed by climate risk within their organizations. Learning Objectives: - Understand the evolving landscape of climate risk and regulatory requirements for climate risk disclosure. - Gain insights into effective approaches and current best practices that actuaries and risk modelers may use in performing qualitative and quantitative climate risk scenario analyses. - Learn practical strategies for integrating climate risk considerations into insurance operations.

Description: At the conclusion of this session, attendees will be equipped to apply relative risk curves in their actuarial work, including the ability to examine dose-response relationships, apply population attributable fractions (PAFs), and develop customized risk models for cause-specific mortality and morbidity outcomes based on individual-level exposures to selected risk factors. These skills are becoming increasingly important as actuaries adopt novel applications of big data and dynamic health information to refine risk assessments and keep pace with global health trends.

Description: El webcast presentará una comparación de alto nivel de los acuerdos internacionales de financiamiento de la atención de la salud y proporcionará una comparación y contrato con los modelos de Colombia y otros modelos latinoamericanos.

Description: "Our Climate Risk Modeling for Life actuaries session will discuss: - The history and future of climate regulations - Climate risk modeling 101 - intersection of short term and long term climate modeling - The role of the actuary in climate risk modeling - The impact actuaries can have globally"

Description: Discover a comparison of U.S. and international mandated leave programs which mandate employers to provide a minimum level of benefits to employees for qualifying leaves of absence, such as parental leave or medical leave.

Description: Speakers representing investment and risk management teams share how they are integrating climate risks into their investment management practices. We will discuss methods to measure and assess climate risks in the investment portfolio, for both transition risks and physical risks. Speakers will also touch on how climate risks can be integrated into the bottom-up investment process. Lastly, we discuss climate-action-oriented programs to decarbonize investment portfolios and their challenges. At the end of this session, participants will be able to: - Understand methods and challenges to measuring exposure to climate risks in their portfolio - Understand methods and challenges in integrating climate risks into the investment process - Understand methods and challenges in implementing decarbonization programs such as Net Zero.

Description: Dive into an integrative approach to Precision Medicine - how our modern capacity to interrogate a disease heterogeneity (from omics and phenotyping) and parallel advances in 'big data' together are driving to transform the practice of traditional medicine to precision medicine. After defining the relevant terminologies and the components of precision medicine, the speaker will walk through the spectrum in precision medicine and how it leads to personalized management of disease, which can impact underwriting approaches, product development and pricing. Diabetes will be used as a specific example.

Description: Our understanding of the biology of aging is increasing rapidly, creating insight into how and why any organism is aging. Some of the mechanisms by which the process of aging occurs in mammals are sufficiently well understood that clinical trials targeting them in humans to improve later life health and longevity are now being undertaken. Translating results seen in mammals to humans has the potential to increase life expectancy far beyond what we have seen historically. Come explore the current state and outlook of research.

Description: "Demographic components of Future Potential Old-Age Support Ratios – Kirill Andreev, Ph.D., United Nations, Population Division, New York, Mila Andreeva, KAMA Consulting Effect of internal Migration on the Health of Taiwan’s Elderly People – Jack C. Yue, Ph.D., – National Chengchi University, Department of Statistics, Taipei, TaiwanPopulation Aging and Canada’s Social Contract: Covid-19 Catalyst for Change – Douglas Andrews, FSA, FCIA, Ph.D., Lori J. Curtis, Ph.D., – University of Waterloo"

Description: "Establishing Methods for Annual Updates to Cohort Life Expectancies – R. Dale Hall, FSA, CERA, MAAAManaging Director of Research, Society of Actuaries Research Institute Longevity Disparity across Communities in the United States – Lijia Guo, Ph.D., ASA, MAAA , US Government Accountability Office, Applied Research and Methods Division, Washington DC"